Corbion reports transactions under its current sha
Post# of 301275
Corbion has repurchased 24,914 of its own common shares in the period from April 18, 2017 up to and including April 21, 2017 at an average price of € 25.81 per share. The consideration of the repurchase was € 642,920.
Corbion's current share buyback program commenced on 18 April 2017, and details are available on our website at http://www.corbion.com/investor-relations/sha...ck-program
This regular update of the transactions conducted under the share buyback program is to be made public under the EU Market Abuse Regulation.
This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.
Background information:
Corbion: biobased solutions, designed by science, powered by nature, and delivered through dedication.
Corbion is the global market leader in lactic acid, lactic acid derivatives and lactides, and a leading company in emulsifiers, functional enzyme blends, minerals and vitamins. The company delivers high performance biobased products made from renewable resources and applied in global markets such as bakery, meat, pharmaceuticals and medical devices, home and personal care, packaging, automotive, coatings and adhesives. Its products have a differentiating functionality in all kinds of consumer products worldwide. In 2016, Corbion generated annual sales of € 911.3 million and had a workforce of 1,684 FTE. Corbion is listed on Euronext Amsterdam. For more information: www.corbion.com
Attachments:
(0)
(0)